Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Possible Genetic Predictors of Cardiovascular Complications After Coronary Artery Bypass Surgery].

Grinshtein YI, Kosinova AA, Grinshtein IY, Subbotina TN, Savchenko AA.

Kardiologiia. 2018 Jul;58(7):77-84. Russian.

PMID:
30081812
2.

The Prognostic Value of Combinations of Genetic Polymorphisms in the ITGB3, ITGA2, and CYP2C19*2 Genes in Predicting Cardiovascular Outcomes After Coronary Bypass Grafting.

Grinshtein YI, Kosinova AA, Grinshtein IY, Subbotina TN, Savchenko AA.

Genet Test Mol Biomarkers. 2018 Apr;22(4):259-265. doi: 10.1089/gtmb.2017.0177. Epub 2018 Feb 20.

PMID:
29461866
3.

High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.

Leé S, Vargová K, Hizoh I, Horváth Z, Gulácsi-Bárdos P, Sztupinszki Z, Apró A, Kovács A, Préda I, Tóth-Zsámboki E, Kiss RG.

Thromb Res. 2014 Feb;133(2):257-64. doi: 10.1016/j.thromres.2013.11.029. Epub 2013 Dec 6.

PMID:
24359966
4.
5.

Genetic determinants of response to clopidogrel and cardiovascular events.

Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators.

N Engl J Med. 2009 Jan 22;360(4):363-75. doi: 10.1056/NEJMoa0808227. Epub 2008 Dec 22.

6.

[Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy].

Muslimova EF, Afanasiev SA, Rebrova TY, Sergienko TN, Repin AN.

Ter Arkh. 2017;89(5):74-78. doi: 10.17116/terarkh201789574-78. Russian.

PMID:
28631703
7.

Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors.

Tomek A, Matʼoška V, Frýdmanová A, Magerová H, Šrámek M, Paulasova-Schwabová J, Růžičková T, Janský P, Šarbochová I, Hadačová I, Kaplan V, Lacinová Z, Táborský L, Serebruany V.

Am J Ther. 2018 Mar/Apr;25(2):e202-e212. doi: 10.1097/MJT.0000000000000416.

PMID:
29509167
8.

Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment.

Giusti B, Gori AM, Marcucci R, Sestini I, Saracini C, Paniccia R, Poli S, Giglioli C, Valente S, Prisco D, Gensini GF, Abbate R.

Atherosclerosis. 2008 Jan;196(1):341-8. Epub 2006 Dec 8.

PMID:
17157856
9.

Effect of platelet receptor gene polymorphisms on outcomes in ST-elevation myocardial infarction patients after percutaneous coronary intervention.

Zhang JH, Wang J, Tang XF, Yao Y, Zhang Y, Ma YL, Xu B, Gao RL, Song L, Gao Z, Chen J, Wu Y, Yang YJ, Meng XM, Yuan JQ.

Platelets. 2016;27(1):75-9. doi: 10.3109/09537104.2015.1034096. Epub 2015 Apr 22.

PMID:
25901734
10.

Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.

Liu R, Zhou ZY, Chen YB, Li JL, Yu WB, Chen XM, Zhao M, Zhao YQ, Cai YF, Jin J, Huang M.

Acta Pharmacol Sin. 2016 Jul;37(7):882-8. doi: 10.1038/aps.2016.41. Epub 2016 May 2.

11.

[Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel].

Cano P, Consuegra-Sánchez L, Conesa P, Torres-Moreno D, Jaulent L, Dau D, Picó F, Villegas M.

Med Clin (Barc). 2014 Jul 7;143(1):6-12. doi: 10.1016/j.medcli.2013.04.042. Epub 2013 Jul 10. Spanish.

PMID:
23850044
12.
13.

Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin.

Jeong YH, Tantry US, Kim IS, Koh JS, Kwon TJ, Park Y, Hwang SJ, Bliden KP, Kwak CH, Hwang JY, Gurbel PA.

Circ Cardiovasc Interv. 2011 Dec 1;4(6):585-94. doi: 10.1161/CIRCINTERVENTIONS.111.962555. Epub 2011 Nov 1.

PMID:
22045970
14.

Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use.

Voora D, Horton J, Shah SH, Shaw LK, Newby LK.

Am Heart J. 2011 Jul;162(1):166-72.e1. doi: 10.1016/j.ahj.2011.03.026.

PMID:
21742104
15.

Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.

Langsenlehner U, Renner W, Yazdani-Biuki B, Eder T, Wascher TC, Paulweber B, Clar H, Hofmann G, Samonigg H, Krippl P.

Breast Cancer Res Treat. 2006 May;97(1):67-72.

PMID:
16317580
16.

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.

Larsen SB, Grove EL, Neergaard-Petersen S, Würtz M, Hvas AM, Kristensen SD.

J Am Heart Assoc. 2017 Aug 5;6(8). pii: e006050. doi: 10.1161/JAHA.117.006050.

17.

Myocardial infarction before and after the age of 45: Possible role of platelet receptor polymorphisms.

Pina-Cabral LB, Carvalhais V, Mesquita B, Escórcio C, Silva PF, Pinto P, Napoleão P, Pinheiro T, Monteiro MC, Almeida-Dias A, Criado B.

Rev Port Cardiol. 2018 Sep;37(9):727-735. doi: 10.1016/j.repc.2018.03.015. Epub 2018 Aug 22. English, Portuguese.

18.

P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.

Bierend A, Rau T, Maas R, Schwedhelm E, Böger RH.

Br J Clin Pharmacol. 2008 Apr;65(4):540-7. Epub 2007 Nov 8.

19.

CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han.

Wang JY, Zhang YJ, Li H, Hu XL, Li MP, Song PY, Ma QL, Peng LM, Chen XP.

Gene. 2018 Dec 15;678:226-232. doi: 10.1016/j.gene.2018.08.027. Epub 2018 Aug 7.

PMID:
30096456
20.

Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.

Zhang L, Chen Y, Jin Y, Qu F, Li J, Ma C, Yang J, Xu B, Wang H, Li X, Li Y, Zhang Y, Lu C, Yin T.

Thromb Res. 2013 Jul;132(1):81-7. doi: 10.1016/j.thromres.2013.05.006. Epub 2013 May 29.

PMID:
23726091

Supplemental Content

Support Center